News

Healthcare, Life Sciences

All news
PulseLife acquiert Invivox et prolonge l'aide à la décision clinique par la formation continue
06/10/2026
Mergers & Acquisitions

PulseLife acquires Invivox and extends clinical decision support to continuing education

The 360 Medical group, parent company of PulseLife, a Lyon-based publisher of a clinical decision support solution, is acquiring Invivox, a continuing medical education platform. The transaction covers the entire share capital. The financial terms have not been disclosed. The new entity presents itself as the first European ecosystem combining decision support and training for […]
Didactic poursuit son développement européen avec l'acquisition de Pearmine Health et de Medadvance
24/09/2026
Mergers & Acquisitions

Didactic pursues its European expansion with the acquisition of Pearmine Health and Medadvance

Didactic, the Normandy-based specialist in single-use medical devices for infection prevention, has announced the acquisition of Pearmine Health, a British company producing hygiene and prevention products, and of Medadvance, its representation and distribution arm based in Germany. Analysis by the experts at Auris Finance, M&A and financial engineering advisory firm. Founded in 1967 and led […]
Clean Cells acquiert Xegen et intègre la bio-informatique à son offre de séquençage
16/09/2026
Mergers & Acquisitions

Clean Cells acquires Xegen and integrates bioinformatics into its sequencing offering

Clean Cells, a Montaigu-Vendée-based company specialising in quality control for biopharmaceutical products and a subsidiary of the Clean Biologics group, has announced the acquisition of Xegen. Based in Gémenos, in the Bouches-du-Rhône, Xegen specialises in the analysis and interpretation of next-generation sequencing data. The transaction supports Clean Cells’ launch of a sequencing-based viral safety testing […]
Astorg finalise l'acquisition de l'activité microbiologie de Thermo Fisher Scientific
28/08/2026
Mergers & Acquisitions

Astorg closes the acquisition of Thermo Fisher Scientific’s microbiology business

Astorg, a pan-European private equity firm specialised in healthcare and life sciences, has announced the closing of the acquisition of Thermo Fisher Scientific‘s microbiology business. The entity becomes a standalone company, led by Dirk Bontridder as CEO, and will operate under a new brand from the end of 2026. Analysis by the experts at Auris […]
Eurofins Scientific renforce sa présence en Amérique du Nord
31/07/2026
Mergers & Acquisitions

Eurofins Scientific strengthens its footprint in North America

Eurofins Scientific has announced that it has entered into an agreement with Element Materials Technology to acquire its life sciences testing services business in North America, for an enterprise value of 400 million dollars. The deal strengthens the group’s network in key US and Canadian regions where it was historically under-represented. Analysis by the experts […]
Cyllene Therapeutics : levée de fonds de 33 M€ en biotech
17/07/2026
Mergers & Acquisitions

Cyllene Therapeutics raises 33 million euros and rebrands to accelerate its EG110A drug candidate

Paris-based biotech Cyllene Therapeutics, formerly known as EG 427, has just closed a 33 million euro Series C. The deal, announced on 7 July 2026, comes with a change of name that marks the company’s shift into a more advanced clinical stage. Analysis by the experts at Auris Finance, advisors in mergers, acquisitions and financial […]
See More